ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells. (October 2021)

• Record Type: Journal Article
• Authors: Amatore, Florent; Ortonne, Nicolas; Lopez, Marc; Orlanducci, Florence; Castellano, Rémy; Ingen-Housz-Oro, Saskia; De Croos, Amandine; Gorvel, Laurent; Goubard, Armelle; Bouabdallah, Réda; Schiano, Jean-Marc; Bonnet, Nathalie; Grob, Jean-Jacques; Gaulard, Philippe; Bagot, Martine; Bensussan, Armand; Delaporte, Emmanuel; Olive, Daniel
• Is Part Of: European journal of cancer. Volume 156(2021)Supplement 1
• Page Start: S23
• Page End: S24
• Publication Date: 2021-10
• Subjects: Inducible co-stimulator (ICOS) -- cutaneous T-cell lymphoma -- antibody–drug conjugate; Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(21)00650-X
• Languages: English
• ISSNs: 0959-8049